Response to Cabergoline treatment in Invasive Prolactinoma with hemorrhage- A case report

Authors

  • Vivek Pant Department of Biochemistry, Institute of Medicine, Maharajgunj, Kathmandu
  • Suman Baral Endocrinology Unit, Institute of Medicine, Maharajgunj, Kathmandu
  • Binod Aryal Department of Biochemistry, Institute of Medicine, Maharajgunj, Kathmandu
  • Arjun Tumbapo Department of Biochemistry, Institute of Medicine, Maharajgunj, Kathmandu

DOI:

https://doi.org/10.3126/jdean.v1i1.21191

Keywords:

cabergoline, prolacti, prolactinoma

Abstract

Patients with invasive prolactinoma present with constellation of symptoms including headache, blurred vision, lethargy, menstrual irregularity and sexual dysfunction. Cabergoline, a potent dopamine agonist, is a known medication prescribed for the treatment of prolactinoma. Here, we report a case of invasive macroprolactinoma with hemorrhage in a 18 years female with dramatic response to cabergoline treatment clinically, biochemically, and radiologically.

Jour of Diab and Endo Assoc of Nepal 2017; 1(1): 18-20

Downloads

Download data is not yet available.
Abstract
422
PDF
570

Downloads

Published

2018-09-28

How to Cite

Pant, V., Baral, S., Aryal, B., & Tumbapo, A. (2018). Response to Cabergoline treatment in Invasive Prolactinoma with hemorrhage- A case report. Journal of Diabetes and Endocrinology Association of Nepal, 1(1), 18–20. https://doi.org/10.3126/jdean.v1i1.21191

Issue

Vol. 1 No. 1 (2017)

Section

Case Reports

License

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for non-commercial purposes only, and only so long as attribution is given to the creator.